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Objectives: The core of advanced atherosclerotic plaques turns hypoxic as the arterial wall thickens and
oxygen diffusion capacity becomes impaired. Macrophage-derived foam cells play a pivotal role in
atherosclerotic plaque formation by expressing scavenger receptors that regulate lipid uptake. However,
the role of hypoxia in scavenger receptor regulation remains incompletely understood.
Methods and results: Using RT-qPCR, ﬂow cytometry and immunoblotting, we found that mRNA and
protein expression levels of the scavenger receptor A (SRA) and the cluster of differentiation 36 (CD36)
were upregulated by oxidized low-density lipoprotein (oxLDL), but decreased following exposure of
macrophages to hypoxia. In contrast, lectin-like oxLDL receptor (Lox-1) mRNA and protein levels were
upregulated under hypoxic conditions. Flow cytometry conﬁrmed the increased lipid content in mac-
rophages after exposure to 0.2% oxygen and the hypoxia-mimetic dimethyloxalylglycine (DMOG).
Antibody-mediated blocking of Lox-1 receptor decreased the hypoxic induction of oxLDL uptake and
lipid content. RNAi-mediated knock-down of hypoxia-inducible factor (HIF)-1a in macrophages atten-
uated the hypoxic induction of Lox-1.
Conclusions: Hypoxia increases lipid uptake into macrophages and differentially regulates the expression
of oxLDL receptors. Lox-1 plays a major role in hypoxia-induced foam cell formation which is, at least in
part, mediated by HIF-1a.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Atherosclerosis is the major cause of myocardial infarction and
stroke and thus constitutes the leading cause of mortality in
Western countries. Atherosclerosis results from the interaction
between oxidized low-density lipoproteins (oxLDL), activated
endothelial cells, monocyte-derived macrophages and the vessel
wall. Transmigration of monocyte-derived macrophages into the
subendothelial space is a key step in atherogenesis. Pro-niversity of Zürich, Winter-
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. Wenger).
Ltd.Open access under CC BY license.inﬂammatory macrophages ingest oxLDL via scavenger receptors
and become foam cells, thereby promoting plaque formation [1,2].
Upon progression of atherosclerosis with plaque thickening, the
supply of nutrients and oxygen to the inner parts of atherosclerotic
plaques becomes diffusion-limited. Sluimer and co-workers pro-
vided evidence for a hypoxic plaque core by pimonidazole staining
of advanced atherosclerotic lesions in symptomatic patients [3].
Oxygen measurements in vitro and in situ conﬁrmed that the oxy-
gen partial pressure in the plaque core inversely correlates with its
size [4]. Furthermore, a recent report showed that hypoxia was
present inmurine atherosclerotic plaques and affectedmacrophage
lipid metabolism [5].
Hypoxia-inducible factor (HIF) is the main stimulator of oxygen-
regulated gene expression. Hypoxia inhibits oxygen-dependent HIF
prolyl-4-hydroxylases (PHDs) enzymatic activity, leading to the
rapid stabilization of HIF a-subunits [6]. In macrophages, oxygen
signaling and inﬂammation cross-talk via NF-kB-induced tran-
scription of the HIF1A gene [7]. While these two conditions are well
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about their role in atherosclerosis. Like in solid tumors, hypoxia and
inﬂammation are increased in the center of atherosclerotic plaques
where they trigger angiogenesis and thus promote plaque growth.
Plaque-derived cytokines, growth factors, and increased endothe-
lial adhesion molecules recruit monocytes to the activated endo-
thelium, promote transmigration to the subendothelial space, and
induce their transdifferentiation into macrophages. This step is
crucial for the progression of atherosclerosis and is associated with
up-regulation of pattern-recognition receptors, including scav-
enger receptors and toll-like receptors. Scavenger receptors inter-
nalize a broad range of molecules and particle-bearing molecules
with pathogen-like molecular patterns. Bacterial endotoxins,
apoptotic fragments, and oxLDL particles are ingested and
destroyed via this pathway. If cholesterol-derived uptake of oxLDL
particles cannot be sufﬁciently removed from the cell, oxLDL par-
ticles accumulate as cytosolic droplets and macrophages are
transformed into foam cells [1,2]. Foam cell decay gives rise to the
necrotic lipid core, a hallmark of advanced atherosclerotic lesions.
It has been reported previously that exposure of human mac-
rophages to hypoxia activates proinﬂammatory pathways such as
the Akt and the b-catenin pathways [8]. Moreover, hypoxia favors
the accumulation of lipid droplets and HIF-1a knock-down inhibits
foam cell formation [9,10]. Foam cell formation is a key event in
both early and late atherosclerotic lesions [11]. Although a number
of proteins may contribute to this process, scavenger receptors A
(SRA), lectin-like oxLDL receptor (Lox-1), and cluster of differenti-
ation 36 (CD36) have been demonstrated to be most relevant for
cholesterol uptake [12]. On the other hand, cholesterol efﬂux or
reverse cholesterol transport (RCT) is regulated by the transporters
ATP binding cassette transporter A1 (ABCA1), ATP binding cassette
transporter G1 (ABCG1), scavenger receptor B (SRB) and others
[13,14].
Several studies have addressed oxygen-regulated RCT. Hypoxia
decreased SRB expression in human monocyte-derived macro-
phages and HIF-1 increased ABCA1 promoter activity along with
ABCA1 expression [15]. However, ABCB1 and ABCC1 were not
regulated by hypoxia in brain microvascular endothelial cells [16].
Sterol regulatory element binding protein 1 (SREBP1) and fatty acid
synthase (FAS) was shown to be upregulated by hypoxia [17], but it
has also been reported that hypoxia suppressed sterol synthesis
[18]. Liver X receptor (LXR) functions as a cholesterol sensor. Its
activation results in a net elimination of cholesterol from the body
and in the reduction of plasma lipoprotein proﬁles by mobilizing
cholesterol. Like SREBP, LXR plays an important role in the regu-
lation of cholesterol homeostasis [19]. Expression of LXR has been
reported to be induced in human primary macrophages and
RAW264.7 cells under hypoxic conditions. A physical interaction
between LXR and HIF-1a could be demonstrated and activation of
these two factors synergistically induced triglyceride accumulation
in macrophages within atherosclerotic plaques [20].
Compared with RCT, less is known about the hypoxia-induced
modulation of scavenger receptors for cholesterol uptake. In
retinal pigment epithelial cells, mRNA and protein levels of CD36
have recently been shown to be upregulated by hypoxia [21].
However, in adipocytes CD36 levels were reduced following hyp-
oxia [22]. Furthermore, hypoxia decreased SRA upregulation by li-
popolysaccharides (LPS), and hypoxia also increased LDL receptor-
related protein-1 (LRP1), respectively [23,24].
Taken together, the data about hypoxia-induced foam cell for-
mation and the associated pathways remain conﬂicting. Both,
increased and decreased cholesterol uptake and efﬂux have been
reported under hypoxic conditions. However, since plaque hypoxia
is associated with a net increase in cholesterol content of macro-
phages, we focused on the mechanisms by which hypoxia affectsthe expression of the three main scavenger receptors SRA, Lox-1,
and CD36 involved in the uptake of modiﬁed LDL.
2. Materials and methods
2.1. Cell culture
Mouse RAW264.7 leukemic monocyte-macrophage cells and
Hepa1 hepatoma cells were grown in DMEM (Sigma). Media were
supplemented with 10% fetal calf serum (FCS) and antibiotics
(50 IU/ml penicillin and 100 mg/ml streptomycin; Gibco-BRL). If not
indicated otherwise, hypoxic cell culture was carried out at 0.2% O2
using a gas-controlled InvivO2400 workstation (Ruskinn Technol-
ogies). Cells were treated with 1 mM of the pan-PHD inhibitor
dimethyloxalylglycine (DMOG) or dimethylsulfoxide (DMSO) as
solvent control. RAW264.7 cells were treated with 10 mg/ml oxLDL
or DiL-oxLDL (KalenBiomed) as indicated.
2.2. Protein extraction and immunoblot analysis
Total soluble cellular proteins were extracted with a high salt
extraction buffer containing 0.4 M NaCl, 0.1% Nonidet P-40, 10 mM
TriseHCl pH 8.0, 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl ﬂuoride and protease inhibitor cocktail (Sigma).
Protein concentrationwas determined by the BCAmethod and 50e
70 mg of cellular protein was subjected to immunoblot analysis.
PVDF membranes were probed using the following dilutions of
mouse monoclonal (mAb), rat monoclonal (ratAb) or rabbit poly-
clonal (rAb) antibodies: mAb HIF-1a (1:1000; BD Transduction
Laboratories), ratAb SRA (1:1000 AbD Serotec), mAb b-actin
(1:5000; Sigma), rAb Lox-1 (1:1000; R&D Systems) or rAb CD36
(1:1000; Abcam), followed by secondary HRP-conjugated anti-
bodies (1:15,000; Pierce). Chemiluminescence signals were devel-
oped using Supersignal West Dura substrate (Pierce). Images were
acquired with a digital light imaging system (LAS 4000; Fuji) and
quantiﬁed using Quantity One software (Bio-Rad).
2.3. mRNA quantiﬁcation
Total RNA puriﬁcation and mRNA determination by reverse-
transcription quantitative PCR (RT-qPCR) using SYBR Green qPCR
reagent kit (Sigma) in combination with a MX3000P light cycler
(Agilent) has been described previously [25]. In brief, 5 mg total RNA
was reverse-transcribed using oligo(dT) primers and Afﬁnityscript
reverse transcriptase (Agilent). mRNA levels were quantiﬁed by
real-time qPCR using 1% of the cDNA reaction. Initial copy number
of each sample was calculated by comparison with serial dilutions
of a calibrated standard. b-Actin was used as a housekeeping con-
trol and all data were expressed as ratios relative to the b-actin
mRNA levels. Primer sequences are listed in Supplementary Table 1.
For construction of the heat map, each value of a certain gene was
divided by the median of all values obtained for this gene within a
single experiment. The mean values of n ¼ 3 independent experi-
ments were displayed in a Log2 scale using JavaTreeView software
[26].
2.4. Short hairpin RNA constructs and lentiviral infections
Expression vectors encoding short hairpin RNA (shRNA) se-
quences targeting mouse HIF-1a and a noncoding control driven by
the U6 promoter in a pLKO.1-puro plasmid were purchased from
Sigma (order numbers TRCN0000054448 and TRCN0000232220).
Viral particles were produced in HEK293Tcells using the ViraPower
lentiviral expression system according to the manufacturer’s in-
structions (Invitrogen).
Fig. 1. Expression patterns of candidate genes involved in oxygen-regulated choles-
terol transport. Heat maps showing the transcript levels of wild-type Hepa1, HIF-b
defective Hepa1C4, and RAW264.7 cells exposed to oxLDL at the indicated oxygen
concentrations for 24 h. Transcript levels were determined by RT-qPCR and normalized
to b-actin mRNA levels. Each value was divided by the median of all values of each
gene to allow the direct comparison of the exogenous regulation independent of the
large cell-type speciﬁc differences in the basal endogenous expression levels. The
mean values of n ¼ 3 independent experiments were displayed in a log2 scale using
JavaTreeView software [26].
Fig. 2. SRA, CD36, and Lox-1 protein expression in hypoxia. Immunoblotting (A, left
panel) and FACS analysis (B, left panel) of SRA, CD36, and Lox-1. RAW264.7 cells were
treated with oxLDL and/or DMOG as indicated and exposed to 20% or 0.2% O2 for 24 h.
DMSO was used as solvent control. Immunoblots were quantiﬁed using a light imager
and protein levels were normalized to b-actin (A, right panel). FACS data were quan-
tiﬁed using GeoMean ﬂuorescence values (B, right panel). *p < 0.05, **p< 0.01, paired t-
test, n ¼ 3 independent experiments for all data shown.
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Single cell suspensions were incubated with antibodies against
SRA, Lox-1 and CD36 (dilution 1:100). Immune complexes were
visualized by FACScanning using goat anti-rabbit antibody-Alexa
488 (dilution 1:1000) for CD36 and Lox-1, or with goat anti-mouse
antibody-Alexa 488 (dilution 1:1000) for SRA (Molecular Probes,
Invitrogen). For lipid uptake experiments, RAW264.7 cells were
seeded in six-well dishes, starved with 0.2% FCS in DMEM for 24 h,
and incubated with or without 10 mg/ml oxLDL or DiL-oxLDL
(Molecular Probes), for 24 h at 20% or 0.2% oxygen. To block Lox-
1, RAW264.7 cells were pre-incubated with 5 mg/ml anti-Lox-1
blocking antibody (RD systems) for 24 h. Lipids were stained with
1e2 mM 1,10-dioctadecyl-6,60-di(4-sulfophenyl)-3,3,30,30-tetrame-
thylindocarbocyanine (SP-DiIC18(3)) ﬂuorescent probe (DiL) (Mo-
lecular Probes), or 3,30-dioctadecyloxacarbocyanine perchlorate
(DiO) (Molecular Probes), for 4 h. The cells were washed twice with
PBS and analyzed with a FACSCantoII and FACSDiva software (BD
Pharmingen). Post-acquisition analysis was done with FlowJo7
software (Tree Star). Alternatively, DiL-stained lipids were visual-
ized by ﬂuorescent microscopy using an Olympus BX51microscope
and analySIS software (Olympus).
2.6. Lipoprotein uptake
RAW264.7 cells were starved for 24 h and then incubated with
10 mg/ml oxLDL for 24 h under normoxic or hypoxic conditions as
described above. After washing, cells were ﬁxed with 4% para-
formaldehyde and stained with Oil red O (ORO; Sigma). ORO
staining was analyzed by light microscopy and quantiﬁed using
analySIS software (Olympus) as previously described [27]. LDL
uptake was quantiﬁed as the ratio between the ORO-positive area
divided by the number of cells as described [28].
2.7. Statistics
If not otherwise indicated, results are presented as mean
values  standard error of the mean of three independent experi-
ments. Column statistics applying paired Student’s t-tests were
calculated using Prism version 4.0 (GraphPad Software).
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3.1. Hypoxia regulates genes involved in cholesterol transport
To elucidate whether hypoxia affects the expression of genes
involved in cholesterol ﬂux, wild-type Hepa1 or HIF-b defective
Hepa1C4 mouse hepatoma cells and RAW264.7 mouse macro-
phages were analyzed for oxygen-dependent expression of candi-
date genes involved in cholesterol transport. The 3,4-benzopyrene-
resistant mutant clone (C4) of the wild-type mouse hepatoma
Hepal cell line contains a Gly326Asp mutation in the crucial PAS
domain of the HIF-b protein (also called aryl hydrocarbon receptor
nuclear translocator, ARNT) which impairs both HIF-b expression
and function. Consequently, HIF-1a (and HIF-2a) heterodimericFig. 3. Role of HIF-1a in the hypoxic regulation of scavenger receptors. Immunoblotting (A,
following lentiviral transduction with short hairpin shHIF-1a or shControl constructs. Cells w
used as solvent control. To determine the hypoxic induction factors (shown in a log2 scale), i
actin, and ratios to the corresponding normoxic experiments calculated (A, right panel). FA
*p < 0.05, paired t-test, n ¼ 3 independent experiments for all data shown.complex formation required for functional DNA binding is severely
attenuated [29e31].
Exposure of these cell lines to pro-inﬂammatory oxLDL under
normoxic (20% O2) or hypoxic (0.2% O2) conditions for 24 h revealed
that hypoxia increased mRNA levels of Lox-1, ABCA1, ABCG1, LXR,
SREBP1, and SREBP cleavage activating protein (SCAP), but
decreased mRNA levels of SRB, SRA, and CD36 (heat map shown in
Fig. 1; raw data are provided in Supplementary Table 2). Experi-
ments performed in Hepa1C4 cells suggested that the increased
expression of SREBP, SCAP, ABCA1, ABCG1 and LXR is HIF-b-
dependent. Hypoxic Lox-1 induction was not fully abrogated in
Hepa1C4 cells (from 6.6 to 2.7-fold) and hence appeared to be
partially HIF-b-independent (Fig. 1). Of note, we and others previ-
ously reported that a sub-fraction of HIF target genes remainleft panel) and FACS analysis (B, left panel) of SRA, CD36, and Lox-1 in RAW264.7 cells
ere treated with oxLDL as indicated and exposed to 20% or 0.2% O2 for 24 h. DMSO was
mmunoblots were quantiﬁed using a light imager, protein levels were normalized to b-
CS data were similarly quantiﬁed using GeoMean ﬂuorescence values (B, right panel).
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sidual HIF-b activity and/or HIF-b-independent signaling pathways
contribute to hypoxia-inducible gene expression in these cells
[30,32,33]. In line with these ﬁndings, hypoxic induction of the
established HIF target gene PHD3 was reduced from 3.4 to 1.3-fold
(Fig. 1). Hypoxia also attenuated oxLDL-induced SRA, CD36, and
SRB, but only SRB attenuation appeared to be at least partially HIF-
dependent in hepatoma cells (Fig. 1).3.2. Hypoxia induces Lox-1 but not SRA or CD36 protein expression
in RAW264.7 macrophages
Using immunoblotting (Fig. 2A) and FACS (Fig. 2B), we next
validated the mRNA data on the protein level. SRA induction by
oxLDL in RAW264.7 cells was less clear on the total protein level
(Fig. 2A) than on the mRNA level (Fig. 1). However, surface SRAwas
again induced by oxLDL under normoxic but not hypoxic conditions
(Fig. 2A). SRA protein regulation was further studied by the pan-
PHD inhibitor DMOG which also signiﬁcantly reduced SRA pro-
tein levels in RAW264.7 cells (Fig. 2A). Hypoxic SRA reduction
persisted for 24 h of mild hypoxia (0.5% or 1% oxygen), and SRA
levels partially recovered after 48 h hypoxia (data not shown). Since
HIF-1a levels were also reduced after 48 h hypoxia (data notFig. 4. Increased lipid content in macrophages under hypoxic conditions. RAW264.7 cells w
solvent control (B), or oxLDL (C) with and without hypoxia. Lipid staining was performed wi
respectively (left panels). DiL ﬂuorescence was quantiﬁed by FACS (right panels). Oil red O an
followed by dividing by the number of cells. FACS data were quantiﬁed using GeoMean ﬂu
shown.shown), these results support an involvement of HIF-1a in hypoxia-
induced SRA repression.
Hypoxia signiﬁcantly attenuated total CD36 protein in the
presence of oxLDL and showed the same tendency in the absence of
oxLDL (Fig. 2A). Because DMOG did not phenocopy this effect
(Fig. 2A), hypoxic CD36 downregulation is most likely HIF-
independent. However, surface CD36 levels appeared to increase
under hypoxic conditions, albeit not to a signiﬁcant extent, in the
presence and absence of oxLDL (Fig. 2B).
In contrast to SRA and CD36, we found a robust hypoxic in-
duction of Lox-1 mRNA in Hepa1 and RAW264.7 cells (Fig. 1). On
the protein level, hypoxia but not oxLDL induced Lox-1 (Fig. 2A).
FACS experiments conﬁrmed the signiﬁcant hypoxic induction of
Lox-1 surface protein expression (Fig. 2B).3.3. HIF-1a is involved in hypoxic Lox-1 induction in RAW264.7
macrophages
The role of HIF-1a in the hypoxic regulation of scavenger re-
ceptors was assessed by RNA interference in RAW264.7 cells.
shRNAs targeting HIF-1a (shHIF-1a), but not a control shRNA
(shControl), efﬁciently downregulated HIF-1a as shown by immu-
noblotting (Fig. 3A, left panel). While HIF-1a knock-down did notere starved in 0.2% FCS for 24 h, followed by exposure to hypoxia (A), DMOG or DMSO
th DiL (4 h) or Oil red O (ORO) (24 h), and detected by ﬂuorescence or light microscopy,
d ﬂuorescence microscopy data were quantiﬁed by determining the total stained area
orescence values. *p < 0.05, paired t-test, n ¼ 3 independent experiments for all data
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resulted in a signiﬁcant decrease of the hypoxic Lox-1 upregulation
(Fig. 3A, right panel). Flow cytometry conﬁrmed the role of HIF-1a
in hypoxic Lox-1 induction also for its surface expression (Fig. 3B).
Of note, HIF-1a knock-down prevented the hypoxic increase in
CD36 surface expression (Fig. 3B).3.4. Hypoxia and DMOG increase lipid content in RAW264.7
macrophages
The differential regulation of the threemain scavenger receptors
does not allow any prediction of how lipid uptake and content
change under hypoxic conditions. Therefore, lipid content was
determined in RAW264.7 cells by the ﬂuorescent dye DiL following
exposure to 0.2% oxygen, DMOG and/or oxLDL for 24 h. DiL-stained
cells were analyzed by ﬂuorescence microscopy (Fig. 4, left panels,
upper rows) and ﬂow cytometry (Fig. 4, right panels). Oil red O
(ORO) staining was visualized by light microscopy and used for
comparison (Fig. 4, left panels, lower rows). Both hypoxia (Fig. 4A)
and DMOG (Fig. 4B) increased the lipid content in RAW264.7 cells
already in the absence of oxLDL, and exposure to oxLDL further
increased the lipid content (Fig. 4C).Fig. 5. Blocking anti-Lox-1 antibodies (a-Lox-1) inhibit lipid uptake in RAW264.7 macropha
oxLDL for 24 h at 20% or 0.2% oxygen, respectively. Where indicated, cells were pretreated w
(ORO) (B) for 4 or 24 h, respectively, and analyzed by ﬂuorescence microscopy (A), light micr
treated RAW264.7 cells were incubated with DiL-labeled oxLDL (DiL-oxLDL) for 24 h and ana
determining the total stained area followed by dividing by the number of cells. FACS data w
paired t-test, n ¼ 3 independent experiments for all data shown.3.5. Lox-1 is necessary for lipid uptake in RAW264.7 macrophages
To assess the role of hypoxic Lox-1 induction, RAW264.7 cells
were treated with blocking anti-Lox-1 antibodies prior to exposure
to hypoxia. Total lipid content was determined by DiO (Fig. 5A) and
ORO staining (Fig. 5B), as well as by DiO staining and ﬂow cytom-
etry (Fig. 5C). To analyze lipid uptake directly, RAW264.7 cells were
treated with ﬂuorescently labeled DiL-oxLDL, exposed to 0.2% ox-
ygen, and evaluated by ﬂow cytometry (Fig. 5D). Both hypoxia-
induced lipid content and uptake were attenuated by blocking
anti-Lox-1 antibodies. These ﬁndings demonstrate the functional
relevance of Lox-1 receptor in mediating hypoxia-induced lipid
uptake and foam cell formation.4. Discussion
Foam cell formation is likely to occur in the core of the
atherosclerotic plaque under hypoxic conditions as a consequence
of decreased oxygen diffusion. Lipid accumulation by foam cells is
mainly due to the uptake of modiﬁed lipoproteins, such as oxLDL
and acLDL. In this study, we demonstrated that hypoxia induced
oxLDL uptake. Interestingly, hypoxia has been reported previouslyges. RAW264.7 cells were starved in 0.2% FCS for 24 h, and incubated with or without
ith a-Lox-1 for 24 h. Their lipid content was determined by adding DiO (A) or Oil red O
oscopy (B) or FACS (C), respectively. To determine lipid uptake, untreated or anti-Lox-1-
lyzed by ﬂow cytometry. Oil red O and ﬂuorescence microscopy data were quantiﬁed by
ere quantiﬁed using GeoMean ﬂuorescence values. *p < 0.05, **p < 0.01, ***p < 0.001,
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of lipoproteins [9]. Various studies have demonstrated that oxLDL
induces HIF-1a accumulation in human macrophages [34,35].
However, our own results do not show any induction of HIF-1a in
RAW264.7 cells after oxLDL treatment, suggesting that this effect
might be cell type-dependent. Glut3, a downstream target of HIF-1,
has been suggested to be required for de novo lipogenesis in
hypoxia-induced lipid loading of human macrophages [36].
Furthermore, fatty acid synthase is upregulated by hypoxia via Akt
and SREBP1 [17], suggesting the contribution of lipid synthesis to
hypoxic foam cell formation in addition to the uptake described in
our study.
Hypoxic SRA downregulation appeared to depend on HIF-1a
both on the total as well as on the surface protein level. In line with
our results, SRA protein levels have been shown to be inhibited by
hypoxia and CoCl2 in RAW264.7 cells [23]. Although a putative
hypoxia response element (HRE) could be identiﬁed in the SRA
promoter at position 578 (data not shown), a direct repressive
effect of HIF-1 on the SRA promoter binding is rather unlikely.
Indeed, HIF-1a has recently been reported not to be associated with
hypoxically repressed genes [37].
Whereas total CD36 protein was not signiﬁcantly altered by
hypoxia, ﬂow cytometry demonstrated CD36 induction on the cell
surface, suggesting CD36 relocalization upon hypoxia. Evidence for
hypoxic CD36 translocation to the plasma membrane has also been
found in cardiac myocytes [38]. While the mechanism by which
hypoxia leads to CD36 relocalisation remained unknown, our data
clearly demonstrate that HIF-1a is involved in this process.
To the best of our knowledge, our study is the ﬁrst one to
demonstrate the importance of Lox-1 for hypoxia-induced lipid
uptake in macrophages. Hypoxia-reoxygenation of cardiomyocytes
has been reported to induce Lox-1 [39], but there are no other
studies on the effects of hypoxia on Lox-1 expression. Lox-1 was
ﬁrst identiﬁed as a scavenger receptor for binding and uptake of
oxLDL in endothelial cells, and it has been shown that Lox-1 plays
important roles in pro-inﬂammatory signaling and atherogenesis
[40]. A cross-talk between hypoxia and inﬂammation has been
further supported by the ﬁnding that both TNF-a and NF-kB
upregulate Lox-1 expression [41]. Thus, our ﬁndings contribute to
the better understanding of the association between hypoxia,
inﬂammation, and hypercholesterolemia.
Using antibody-mediated blocking of Lox-1, we showed Lox-1 to
be required for uptake of oxLDL under hypoxic conditions. Hypoxia
only slightly stimulated the uptake of acLDL which was not affected
by the anti-Lox-1 antibody (data not shown). These observations
suggest that Lox-1 mainly mediates the uptake of LDL following
oxidative modiﬁcation by an inﬂammatory milieu. Bioinformatic
analysis identiﬁed a putative HRE in the Lox-1 promoter at
position 114 (data not shown) which might mediate the HIF
effect.
Taken together, we found that Lox-1 is upregulated in hypoxic
macrophages, whereas SRA and CD36 are decreased. We propose
that HIF-1a is involved in Lox-1 upregulation, thereby enhancing
oxLDL uptake. We extrapolate that upon progression of human
atherosclerotic lesions, the core of plaques becomes hypoxic,
thereby accelerating foam cell formation in thick atheromata dur-
ing advanced stages of atherogenesis.
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